Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13786909 | 0.89 | ALDH1A1 (0.38) | ALDH1A1TSHR | |
| SCHEMBL10951579 | 0.86 | ALDH1A1 (0.39) | ALDH1A1TSHR | |
| SCHEMBL4168233 | 0.80 | TSHR (0.44) | ALDH1A1TSHR | |
| SCHEMBL13786928 | 0.77 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| SCHEMBL12000454 | 0.76 | ALDH1A1 (0.46) | ALDH1A1TSHR | |
| SCHEMBL15095421 | 0.76 | ALDH1A1 (0.46) | ALDH1A1TSHR | |
| SCHEMBL20251191 | 0.74 | ALDH1A1 (0.49) | ALDH1A1TSHR | |
| SCHEMBL16522363 | 0.74 | ALDH1A1 (0.49) | ALDH1A1TSHR | |
| SCHEMBL20251160 | 0.74 | ALDH1A1 (0.49) | ALDH1A1TSHR | |
| SCHEMBL20251162 | 0.74 | ALDH1A1 (0.49) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090169985-A1 | ELECTROLYTIC SOLUTION, SECONDARY BATTERY AND METHOD OF MANUFACTURING SAME, AND SULFONE COMPOUND | SONY CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090169985-A1 | ELECTROLYTIC SOLUTION, SECONDARY BATTERY AND METHOD OF MANUFACTURING SAME, AND SULFONE COMPOUND | CA12, CA1, STS | ALDH1A1 502/4885TSHR 3173/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.